Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability.
Hugenberg V, Hermann S, Galla F, Schäfers M, Wünsch B, Kolb HC, Szardenings K, Lebedev A, Walsh JC, Mocharla VP, Gangadharmath UB, Kopka K, Wagner S. Hugenberg V, et al. Among authors: wunsch b. Nucl Med Biol. 2016 Jul;43(7):424-37. doi: 10.1016/j.nucmedbio.2016.03.005. Epub 2016 Mar 17. Nucl Med Biol. 2016. PMID: 27179748
Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists.
Bourgeois C, Werfel E, Galla F, Lehmkuhl K, Torres-Gómez H, Schepmann D, Kögel B, Christoph T, Straßburger W, Englberger W, Soeberdt M, Hüwel S, Galla HJ, Wünsch B. Bourgeois C, et al. Among authors: wunsch b. J Med Chem. 2014 Aug 14;57(15):6845-60. doi: 10.1021/jm500940q. Epub 2014 Aug 5. J Med Chem. 2014. PMID: 25062506
Synthesis, binding affinity and structure-activity relationships of novel, selective and dual targeting CCR2 and CCR5 receptor antagonists.
Junker A, Kokornaczyk AK, Zweemer AJ, Frehland B, Schepmann D, Yamaguchi J, Itami K, Faust A, Hermann S, Wagner S, Schäfers M, Koch M, Weiss C, Heitman LH, Kopka K, Wünsch B. Junker A, et al. Among authors: wunsch b. Org Biomol Chem. 2015 Feb 28;13(8):2407-22. doi: 10.1039/c4ob02397h. Org Biomol Chem. 2015. PMID: 25566983
Comparison of in Silico, Electrochemical, in Vitro and in Vivo Metabolism of a Homologous Series of (Radio)fluorinated σ1 Receptor Ligands Designed for Positron Emission Tomography.
Wiese C, Große Maestrup E, Galla F, Schepmann D, Hiller A, Fischer S, Ludwig FA, Deuther-Conrad W, Donat CK, Brust P, Büter L, Karst U, Wünsch B. Wiese C, et al. Among authors: wunsch b. ChemMedChem. 2016 Nov 7;11(21):2445-2458. doi: 10.1002/cmdc.201600366. Epub 2016 Sep 28. ChemMedChem. 2016. PMID: 27677767
Synthesis and evaluation of a [18F]BODIPY-labeled caspase-inhibitor.
Ortmeyer CP, Haufe G, Schwegmann K, Hermann S, Schäfers M, Börgel F, Wünsch B, Wagner S, Hugenberg V. Ortmeyer CP, et al. Among authors: wunsch b. Bioorg Med Chem. 2017 Apr 1;25(7):2167-2176. doi: 10.1016/j.bmc.2017.02.033. Epub 2017 Feb 16. Bioorg Med Chem. 2017. PMID: 28284866
Design, (Radio)Synthesis, and in Vitro and in Vivo Evaluation of Highly Selective and Potent Matrix Metalloproteinase 12 (MMP-12) Inhibitors as Radiotracers for Positron Emission Tomography.
Butsch V, Börgel F, Galla F, Schwegmann K, Hermann S, Schäfers M, Riemann B, Wünsch B, Wagner S. Butsch V, et al. Among authors: wunsch b. J Med Chem. 2018 May 10;61(9):4115-4134. doi: 10.1021/acs.jmedchem.8b00200. Epub 2018 Apr 27. J Med Chem. 2018. PMID: 29660282
321 results